Burden of disease assessment with summary measures of population health for the region of valencia
•
0 likes•135 views
Burden of disease assessment with summary measures of population health for the region of valencia
Report
Share
Report
Share
Download to read offline
Recommended
How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment?
An Elicitation of Patients’ Preferences by Analytic Hierarchy Process (AHP)
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment
Jackie Tran, MD
University of Medicine and Dentistry of New Jersey, USA
HTAi 9th Annual Meeting, Bilbao
Integrated Care for a Patient Centered System
25 June, 2012
Health Technology Assessment (HTA) Report: Interventions to increase particip...
The document summarizes a Health Technology Assessment report on interventions to increase participation in organized cancer screening programs. It found that mail and phone recalls, as well as having a general practitioner's signature on the invitation letter, consistently increased participation. Fixed appointments also increased participation compared to open invitations. Self-sampling for HPV testing increased participation in non-responders relative to standard recall letters. The report evaluated interventions' efficacy, cost-effectiveness, organizational impact, and social/ethical issues.
The use of ‘colloquial evidence’ in HTA: the experience of NICE
The document summarizes a presentation given at the HTAi Annual Meeting about the National Institute for Health and Care Excellence's (NICE) use of "colloquial evidence" in developing clinical guidance. It defines colloquial evidence, explores how NICE utilizes it alongside scientific evidence at different stages of the guidance process, and discusses developing better methods for identifying and critically appraising colloquial evidence. The presentation aims to map NICE's use of colloquial evidence to an existing conceptual framework and identify variations across NICE centers.
Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ensure fair allocation of health care resources .
HTAi Conference 2012 Panel Session
Joint chairs
Professor Peter Littlejohns and Professor Albert Weale
Challenges in commissioning research on what works in integrated care
This document discusses challenges in commissioning research on integrated care and how new studies are tackling these challenges. Integrated care research is complex due to the interplay of context, mechanisms and outcomes, and difficulty tracking activity and costs across settings. New studies are using more robust methods like difference-in-difference analysis across multiple sites and person-linked data to better understand costs and impacts. They are also considering generalizability and using mixed methods to understand how micro-level integrated care can be supported at higher levels.
Building a portfolio of research findings for use by healthcare managers and ...
The document summarizes research conducted by the NIHR Health Services and Delivery Research programme on integrated care. It outlines several research projects funded through specific calls on integrated care between 2009-2011, including evaluations of case management initiatives, self-care support, and virtual wards. The research aims to identify healthcare managers' needs and generate evidence to improve services. The programme commissions applied health research to benefit the NHS based on both need and scientific merit.
Assessing the International Use
This document summarizes a study exploring methods for assessing international use of UK-funded health technology assessments (HTAs). The study reviewed literature on impact assessment models and explored bibliometrics, website analytics, and citations in HTA reports. Bibliometric analysis found low international academic impact. Website analytics revealed most non-UK visits were for systematic reviews. Citations in HTA reports provided some evidence of international uptake. The study recommends a multidimensional model and further research using case studies to explore nature of HTA use internationally.
Recommended
How Glaucoma Patients Assess Different Aspects of Their Treatment? An Elicit...
How Glaucoma Patients Assess Different Aspects of Their Treatment?
An Elicitation of Patients’ Preferences by Analytic Hierarchy Process (AHP)
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Healt...
Transitional Care for Pediatric Patients with Neuromuscular Diseases: A Health Technology Assessment
Jackie Tran, MD
University of Medicine and Dentistry of New Jersey, USA
HTAi 9th Annual Meeting, Bilbao
Integrated Care for a Patient Centered System
25 June, 2012
Health Technology Assessment (HTA) Report: Interventions to increase particip...
The document summarizes a Health Technology Assessment report on interventions to increase participation in organized cancer screening programs. It found that mail and phone recalls, as well as having a general practitioner's signature on the invitation letter, consistently increased participation. Fixed appointments also increased participation compared to open invitations. Self-sampling for HPV testing increased participation in non-responders relative to standard recall letters. The report evaluated interventions' efficacy, cost-effectiveness, organizational impact, and social/ethical issues.
The use of ‘colloquial evidence’ in HTA: the experience of NICE
The document summarizes a presentation given at the HTAi Annual Meeting about the National Institute for Health and Care Excellence's (NICE) use of "colloquial evidence" in developing clinical guidance. It defines colloquial evidence, explores how NICE utilizes it alongside scientific evidence at different stages of the guidance process, and discusses developing better methods for identifying and critically appraising colloquial evidence. The presentation aims to map NICE's use of colloquial evidence to an existing conceptual framework and identify variations across NICE centers.
Social values international programme: integrating research and policy to ens...
Social values international programme: integrating research and policy to ensure fair allocation of health care resources .
HTAi Conference 2012 Panel Session
Joint chairs
Professor Peter Littlejohns and Professor Albert Weale
Challenges in commissioning research on what works in integrated care
This document discusses challenges in commissioning research on integrated care and how new studies are tackling these challenges. Integrated care research is complex due to the interplay of context, mechanisms and outcomes, and difficulty tracking activity and costs across settings. New studies are using more robust methods like difference-in-difference analysis across multiple sites and person-linked data to better understand costs and impacts. They are also considering generalizability and using mixed methods to understand how micro-level integrated care can be supported at higher levels.
Building a portfolio of research findings for use by healthcare managers and ...
The document summarizes research conducted by the NIHR Health Services and Delivery Research programme on integrated care. It outlines several research projects funded through specific calls on integrated care between 2009-2011, including evaluations of case management initiatives, self-care support, and virtual wards. The research aims to identify healthcare managers' needs and generate evidence to improve services. The programme commissions applied health research to benefit the NHS based on both need and scientific merit.
Assessing the International Use
This document summarizes a study exploring methods for assessing international use of UK-funded health technology assessments (HTAs). The study reviewed literature on impact assessment models and explored bibliometrics, website analytics, and citations in HTA reports. Bibliometric analysis found low international academic impact. Website analytics revealed most non-UK visits were for systematic reviews. Citations in HTA reports provided some evidence of international uptake. The study recommends a multidimensional model and further research using case studies to explore nature of HTA use internationally.
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPTANCE OF TELEMONITORING FOR CHRONIC PATIENTS
Estibalitz Orruño1, Marie-Pierre Gagnon2-3, José Asua4, Eva Reviriego1
1 Basque Office for Health Technology Assessment (Osteba), Department of Health and Consumer Affairs, Basque Government, Vitoria-Gasteiz, Spain.
2 Faculty of Nursing Sciences, Université Laval, Québec, Canada.
3 Research Centre of the Centre Hospitalier Universitaire de Québec, Québec, Canada.
4 Direction of Knowledge Management and Evaluation, Department of Health and Consumer Affairs, Basque Government, Vitoria-Gasteiz, Spain.
On the outside looking in.
The document discusses improving opportunities for patient and consumer engagement in health technology assessment (HTA) in Australia. It notes that while mechanisms exist for patient input, the overall HTA process is not well understood, advocacy groups are under-resourced, and the timeline for submissions is short. It proposes the formation of HTA_AUS, a coalition of interested parties including patient groups, government, industry and others, to address this issue and develop practical solutions like supporting patient submissions and extending deadlines. The coalition aims to increase awareness, education and support for patient engagement in HTA.
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATION: SOLUTIONS DEVELOPED IN THE IFEDH FRAMEWORK
G. Zauner
dwh Simulation Services
Vienna , Austria
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatments in France?
HTAi 2012, Bilbao
Clémence Thébaut, Olivier Scemama, Françoise Hamers, Catherine Rumeau-Pichon
Department of economic and public health evaluation
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects database
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' support
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual technology decision level part 2
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degeneration
The application of Health Technology Assessment in the field of biologics: an...
This document provides a health technology assessment of etanercept for treating rheumatoid arthritis. It includes 7 chapters that evaluate the epidemiology and burden of RA, biologic drugs for RA including etanercept, the economic impacts, organizational implications, and ethical considerations of using etanercept. The assessment finds that etanercept improves quality of life when combined with methotrexate compared to methotrexate alone, and has a cost-effectiveness ratio of €25,130 per quality-adjusted life year gained, making it a reasonable treatment option.
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
This document summarizes a study on hospital-based health technology assessment (HB HTA) in Italy. The study aimed to assess the diffusion of HB HTA, its impact on hospital decisions, and potential factors influencing its effectiveness. A survey found that almost half of hospitals have an HTA commission. While few clear impacts were identified, some relationships were found between HTA characteristics and resource use. Future research should evaluate additional outcomes to better understand HB HTA's effects and inform its adoption.
Measuring the Gap between Demand and Access in the Brazilian Public Health Ca...
This document reviews the gap between demand and access to medicines in Brazil's public health care system. It finds that while over 70% of medical consultations are publicly funded, around 70% of medicines are privately purchased due to high prices and limited availability in public pharmacies. This shifts the financial burden to users and disproportionately harms those who cannot afford treatment, increasing inequality. The document calls for improvements in budget forecasting, health planning, and data collection to better measure and address variations in access to medicines across regions and types of treatments.
MAST: a model for HTA-based assessment of telemedicine applications
This document describes MAST (Model for Assessment of Telemedicine), a multidisciplinary framework for assessing telemedicine applications. It was developed through a comprehensive process and aims to describe effectiveness and quality of care impacts of telemedicine. MAST consists of 3 stages: setting context, multidisciplinary assessment across clinical, economic, organizational and social domains, and assessing transferability. It is being empirically tested through large European projects and has supported over 25 trials. While time-consuming, MAST provides a standardized approach and ensures comparability. Feedback has been positive and several regions are adopting it, with revisions planned based on empirical results to establish MAST as a widely accepted methodology.
Decision making in management for large medical equipment
This document discusses decision making for purchasing large medical equipment like MRI machines. It presents data showing differences in MRI availability between countries. There are challenges in decision making due to varying supplier policies, objectives of health facilities, and heterogeneous information. A methodology is proposed to help with rational choice involving developing a system for equipment selection and procurement. Experts would be evaluated and their competence indexed based on both objective and subjective criteria. Analytical hierarchy process (AHP) techniques could be applied to determine priority weights for MRI machine characteristics through pairwise comparisons. Predictions could also be made on how weights may change. This would help create a ranked list of recommended MRI machine options.
Quantifying the clinical benefits of new imaging technologies: A technology a...
Quantifying the clinical benefits of new imaging technologies: A technology assessment of EOS® 2D/3D X-ray imaging system
Representing uncertainty and its consequences in cost-effectiveness analyses
i) A decision to adopt clopidogrel for 12 months (clop12) has a 52.4% chance of being cost-effective but there is significant uncertainty with a 47.6% chance of error.
ii) The expected consequences of this uncertainty are 5,194 QALYs. Alternative scenarios show lower expected consequences ranging from 3,969 QALYs.
iii) Natural history parameters like mortality and relative treatment effect parameters have the greatest influence on decision uncertainty. Conducting research to reduce uncertainty around these parameters could help resolve over 5,000 QALYs of expected decision uncertainty.
Abordajes para la estimación de carga de enfermedad en rotavirus y neumococo
Este documento resume los principales abordajes utilizados para estimar la carga de enfermedad por rotavirus y neumococo en estudios realizados en Latinoamérica. Los dos abordajes más comunes fueron aquellos basados en incidencia o resultados intermedios. La fuente de datos más utilizada fueron estudios publicados y en segundo lugar estadísticas vitales. Se concluye que existe la necesidad de realizar más estudios de carga de enfermedad en la región y que este abordaje propuesto y el manual mencionado pretenden promover y facilitar
Diabetes presentation dr mohammed abuelkhair logo
The document identifies opportunities to enhance prescribing efficiency for diabetes patients in Abu Dhabi, such as increasing the use of generic medications, modified release preparations, and cost-effective agents. It analyzes prescribing trends across different healthcare facilities and recommends strategies to improve quality of care and reduce costs, including promoting evidence-based prescribing of first-line therapies.
Presentation scotland bbg logo
This document analyzes initiatives in Scotland to enhance prescribing efficiency for cardiovascular drugs, proton pump inhibitors, and atypical antipsychotics. It finds that education, economics, and engineering measures successfully increased the use of generic omeprazole, simvastatin, and ACE inhibitors, controlling expenditures. However, the availability of generic risperidone did not increase its use relative to other atypical antipsychotics, limiting potential savings. The analysis suggests multiple demand-side measures are needed across therapeutic classes to maximize efficiency gains from lower-cost generics.
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Top Effective Soaps for Fungal Skin Infections in India
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
More Related Content
More from HTAi Bilbao 2012
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPTANCE OF TELEMONITORING FOR CHRONIC PATIENTS
Estibalitz Orruño1, Marie-Pierre Gagnon2-3, José Asua4, Eva Reviriego1
1 Basque Office for Health Technology Assessment (Osteba), Department of Health and Consumer Affairs, Basque Government, Vitoria-Gasteiz, Spain.
2 Faculty of Nursing Sciences, Université Laval, Québec, Canada.
3 Research Centre of the Centre Hospitalier Universitaire de Québec, Québec, Canada.
4 Direction of Knowledge Management and Evaluation, Department of Health and Consumer Affairs, Basque Government, Vitoria-Gasteiz, Spain.
On the outside looking in.
The document discusses improving opportunities for patient and consumer engagement in health technology assessment (HTA) in Australia. It notes that while mechanisms exist for patient input, the overall HTA process is not well understood, advocacy groups are under-resourced, and the timeline for submissions is short. It proposes the formation of HTA_AUS, a coalition of interested parties including patient groups, government, industry and others, to address this issue and develop practical solutions like supporting patient submissions and extending deadlines. The coalition aims to increase awareness, education and support for patient engagement in HTA.
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATION: SOLUTIONS DEVELOPED IN THE IFEDH FRAMEWORK
G. Zauner
dwh Simulation Services
Vienna , Austria
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatments in France?
HTAi 2012, Bilbao
Clémence Thébaut, Olivier Scemama, Françoise Hamers, Catherine Rumeau-Pichon
Department of economic and public health evaluation
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects database
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' support
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual technology decision level part 2
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degeneration
The application of Health Technology Assessment in the field of biologics: an...
This document provides a health technology assessment of etanercept for treating rheumatoid arthritis. It includes 7 chapters that evaluate the epidemiology and burden of RA, biologic drugs for RA including etanercept, the economic impacts, organizational implications, and ethical considerations of using etanercept. The assessment finds that etanercept improves quality of life when combined with methotrexate compared to methotrexate alone, and has a cost-effectiveness ratio of €25,130 per quality-adjusted life year gained, making it a reasonable treatment option.
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
This document summarizes a study on hospital-based health technology assessment (HB HTA) in Italy. The study aimed to assess the diffusion of HB HTA, its impact on hospital decisions, and potential factors influencing its effectiveness. A survey found that almost half of hospitals have an HTA commission. While few clear impacts were identified, some relationships were found between HTA characteristics and resource use. Future research should evaluate additional outcomes to better understand HB HTA's effects and inform its adoption.
Measuring the Gap between Demand and Access in the Brazilian Public Health Ca...
This document reviews the gap between demand and access to medicines in Brazil's public health care system. It finds that while over 70% of medical consultations are publicly funded, around 70% of medicines are privately purchased due to high prices and limited availability in public pharmacies. This shifts the financial burden to users and disproportionately harms those who cannot afford treatment, increasing inequality. The document calls for improvements in budget forecasting, health planning, and data collection to better measure and address variations in access to medicines across regions and types of treatments.
MAST: a model for HTA-based assessment of telemedicine applications
This document describes MAST (Model for Assessment of Telemedicine), a multidisciplinary framework for assessing telemedicine applications. It was developed through a comprehensive process and aims to describe effectiveness and quality of care impacts of telemedicine. MAST consists of 3 stages: setting context, multidisciplinary assessment across clinical, economic, organizational and social domains, and assessing transferability. It is being empirically tested through large European projects and has supported over 25 trials. While time-consuming, MAST provides a standardized approach and ensures comparability. Feedback has been positive and several regions are adopting it, with revisions planned based on empirical results to establish MAST as a widely accepted methodology.
Decision making in management for large medical equipment
This document discusses decision making for purchasing large medical equipment like MRI machines. It presents data showing differences in MRI availability between countries. There are challenges in decision making due to varying supplier policies, objectives of health facilities, and heterogeneous information. A methodology is proposed to help with rational choice involving developing a system for equipment selection and procurement. Experts would be evaluated and their competence indexed based on both objective and subjective criteria. Analytical hierarchy process (AHP) techniques could be applied to determine priority weights for MRI machine characteristics through pairwise comparisons. Predictions could also be made on how weights may change. This would help create a ranked list of recommended MRI machine options.
Quantifying the clinical benefits of new imaging technologies: A technology a...
Quantifying the clinical benefits of new imaging technologies: A technology assessment of EOS® 2D/3D X-ray imaging system
Representing uncertainty and its consequences in cost-effectiveness analyses
i) A decision to adopt clopidogrel for 12 months (clop12) has a 52.4% chance of being cost-effective but there is significant uncertainty with a 47.6% chance of error.
ii) The expected consequences of this uncertainty are 5,194 QALYs. Alternative scenarios show lower expected consequences ranging from 3,969 QALYs.
iii) Natural history parameters like mortality and relative treatment effect parameters have the greatest influence on decision uncertainty. Conducting research to reduce uncertainty around these parameters could help resolve over 5,000 QALYs of expected decision uncertainty.
Abordajes para la estimación de carga de enfermedad en rotavirus y neumococo
Este documento resume los principales abordajes utilizados para estimar la carga de enfermedad por rotavirus y neumococo en estudios realizados en Latinoamérica. Los dos abordajes más comunes fueron aquellos basados en incidencia o resultados intermedios. La fuente de datos más utilizada fueron estudios publicados y en segundo lugar estadísticas vitales. Se concluye que existe la necesidad de realizar más estudios de carga de enfermedad en la región y que este abordaje propuesto y el manual mencionado pretenden promover y facilitar
Diabetes presentation dr mohammed abuelkhair logo
The document identifies opportunities to enhance prescribing efficiency for diabetes patients in Abu Dhabi, such as increasing the use of generic medications, modified release preparations, and cost-effective agents. It analyzes prescribing trends across different healthcare facilities and recommends strategies to improve quality of care and reduce costs, including promoting evidence-based prescribing of first-line therapies.
Presentation scotland bbg logo
This document analyzes initiatives in Scotland to enhance prescribing efficiency for cardiovascular drugs, proton pump inhibitors, and atypical antipsychotics. It finds that education, economics, and engineering measures successfully increased the use of generic omeprazole, simvastatin, and ACE inhibitors, controlling expenditures. However, the availability of generic risperidone did not increase its use relative to other atypical antipsychotics, limiting potential savings. The analysis suggests multiple demand-side measures are needed across therapeutic classes to maximize efficiency gains from lower-cost generics.
More from HTAi Bilbao 2012 (20)
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
EVALUATION OF PSYCHOSOCIAL FACTORS INFLUENCING HEALTHCARE PROFESSIONAL ACCEPT...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
METHODS, MATHEMATICAL MODELS, DATA QUALITY ASSESSMENT AND RESULT INTERPRETATI...
How to promote the prescription of evidence-based non-pharmacological treatme...
How to promote the prescription of evidence-based non-pharmacological treatme...
The eunethta planned and ongoing projects database
The eunethta planned and ongoing projects database
Evaluation of an e health intervention for cancer patients' support
Evaluation of an e health intervention for cancer patients' support
Classification of oecd countries reimbursement systems at the individual tech...
Classification of oecd countries reimbursement systems at the individual tech...
Bevacizumab for neovascular age related macular degeneration
Bevacizumab for neovascular age related macular degeneration
The application of Health Technology Assessment in the field of biologics: an...
The application of Health Technology Assessment in the field of biologics: an...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Hospital-based HTA: does it impact on medical technologies’ expenditure and c...
Measuring the Gap between Demand and Access in the Brazilian Public Health Ca...
Measuring the Gap between Demand and Access in the Brazilian Public Health Ca...
MAST: a model for HTA-based assessment of telemedicine applications
MAST: a model for HTA-based assessment of telemedicine applications
Decision making in management for large medical equipment
Decision making in management for large medical equipment
Quantifying the clinical benefits of new imaging technologies: A technology a...
Quantifying the clinical benefits of new imaging technologies: A technology a...
Representing uncertainty and its consequences in cost-effectiveness analyses
Representing uncertainty and its consequences in cost-effectiveness analyses
Abordajes para la estimación de carga de enfermedad en rotavirus y neumococo
Abordajes para la estimación de carga de enfermedad en rotavirus y neumococo
Recently uploaded
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Top Effective Soaps for Fungal Skin Infections in India
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
Journal Article Review on Rasamanikya
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Top-Vitamin-Supplement-Brands-in-India List
Swisschem Dermacare provides the Top 10 Vitamin Supplement Brands in India. To know more about us give us call at our official number
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
vonoprazan A novel drug for GERD presentation
Vonoprazan, a new potassium acid channel blocker used in the conditions of GERD and gastric ulcer, duodenal ulcer ....
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Study Guide Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Course Hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Answers Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Course hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Study Guide Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Ebook Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Questions Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Stuvia
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation. All info about Diabetes and how to control it.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
Recently uploaded (20)
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx